Distress Management

2007 ◽  
Vol 5 (1) ◽  
pp. 66 ◽  
Author(s):  
_ _
Keyword(s):  
Clinical Practice ◽  
Cancer Patients ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Cancer Care ◽  
Diagnosis And Treatment ◽  
Ambulatory Setting ◽  
Waiting Room ◽  
Patients Experience ◽  
Recent Version

All patients experience some level of distress at various stages of the diagnosis and treatment of cancer. Physicians' ability to recognize patients' distress has become more challenging as cancer care has shifted to the ambulatory setting, where visits are often short and rushed. Therefore, using clinical practice guidelines for managing psychosocial distress in cancer patients is critical. These guidelines recommend that each new patient be rapidly assessed in the office or clinic waiting room for evidence of distress. For the most recent version of the guidelines, please visit NCCN.org

Adult Cancer Pain

2007 ◽  
Vol 5 (8) ◽  
pp. 824
Author(s):  
_ _
Keyword(s):  
Quality Of Life ◽  
Clinical Practice ◽  
Cancer Pain ◽  
National Comprehensive Cancer Network ◽  
Cancer Patients ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Cancer Network ◽  
Recent Version

Pain is one of the most common symptoms associated with cancer and one of the symptoms patients fear most; unrelieved pain denies them comfort and greatly affects their activities, motivation, interactions with family and friends, and overall quality of life. The importance of relieving pain and availability of effective therapies make it imperative that clinicians caring for cancer patients to be adept at assessing and treating cancer pain. The National Comprehensive Cancer Network Adult Cancer Pain Clinical Practice Guidelines in Oncology acknowledge the range of complex decisions faced in caring for these patients. As a result, they provide dosing guidelines for NSAIDs, opioids, and adjuvant analgesics. They also provide specific suggestions for escalating opioid dosage, managing opioid toxicity, and when and how to proceed to other techniques to manage cancer pain. For the most recent version of the guidelines, please visit NCCN.org

scholarly journals Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea

2021 ◽  
Vol 53 (2) ◽  
pp. 323-329
Author(s):  
Jii Bum Lee ◽  
Minkyu Jung ◽  
June Hyuk Kim ◽  
Bo Hyun Kim ◽  
Yeol Kim ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Severe Acute Respiratory Syndrome ◽  
Cancer Patients ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Cancer Care ◽  
Task Force ◽  
World Health ◽  
The World ◽  
Health Organization

At the end of 2019, the cause of pneumonia outbreaks in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In February 2020, the World Health Organization named the disease cause by SARS-CoV-2 as coronavirus disease 2019 (COVID-19). In response to the pandemic, the Korean Cancer Association formed the COVID-19 task force to develop practice guidelines. This special article introduces the clinical practice guidelines for cancer patients which will help oncologists best manage cancer patients during the COVID-19 pandemic.

Cancer-Related Fatigue Clinical Practice Guidelines in Oncology

2003 ◽  
Vol 1 (3) ◽  
pp. 308 ◽  
Keyword(s):  
Clinical Practice ◽  
Cancer Survivors ◽  
Patient Care ◽  
Cancer Patients ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Cancer Related Fatigue ◽  
Dose Dense ◽  
Recent Version ◽  
Prevalence Of Cancer

The problem of cancer-related fatigue, which affects 70% to 100% of cancer patients, has been exacerbated by the increased use of fatigue-inducing multimodal treatments and dose-dense, dose-intense protocols. In patients with metastatic disease, the prevalence of cancer-related fatigue exceeds 75%, and cancer survivors report that fatigue is a disruptive symptom months or even years after treatment ends. To address the significant problem of cancer-related fatigue, the NCCN convened a panel of experts in the field of fatigue. The Cancer-Related Fatigue Clinical Practice Guidelines synthesize the available research and clinical experience in this field and provide recommendations for patient care. For the most recent version of the guidelines, please visit NCCN.org

scholarly journals Russian Association of Endocrinologists clinical practice guidelines for thyrotoxicosis diagnosis and treatment

2014 ◽  
Vol 10 (3) ◽  
pp. 8 ◽  
Author(s):  
Ekaterina Anatolyevna Troshina ◽  
Natalya Yuryevna Sviridenko ◽  
Vladimir Eduardovich Vanushko ◽  
Pavel Olegovich Rumyantsev ◽  
Valentin Viktorovich Fadeyev ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Diagnosis And Treatment ◽  
Russian Association

scholarly journals 2016 Russian clinical practice guidelines for differentiated thyroid cancer diagnosis and treatment

2017 ◽  
Vol 11 (1) ◽  
pp. 6-27 ◽  
Author(s):  
Dmitriy G. Beltsevich ◽  
Vladimir E. Vanushko ◽  
Pavel O. Rumiantsev ◽  
Galina A. Melnichenko ◽  
Nikolay S. Kuznetsov ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Clinical Practice ◽  
Cancer Diagnosis ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Differentiated Thyroid Cancer ◽  
Diagnosis And Treatment

В представленных клинических рекомендациях обсуждаются современные подходы к диагностике и лечению дифференцированного рака щитовидной железы у взрослых. Изменения в настоящей редакции Клинических рекомендаций касаются показаний к пункционной биопсии, скринингового определения концентрации кальцитонина, унификации заключений цитологического исследования, новых подходах к послеоперационной динамической стратификации риска рецидива, показаний к супрессивной и заместительной терапии, таргетной терапии йоднегативных форм дифференцированного рака щитовидной железы.

Sign in / Sign up

Export Citation Format

Share Document